Pioneering breakthroughs in the treatment of fibrotic diseases

Our mission is to be a world class anti-fibrotic company by developing innovative, targeted therapeutics to treat serious, often life-threatening fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy and focal segmental glomerulosclerosis.